Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome
Journal of Clinical Medicine · 29.03.2024 · 13 (7) · 1988
DOI: 10.3390/jcm13071988 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.03.2024. Verfasst von Fernanda Isadora Corona-Meraz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Multidisciplinary Health Research Center, Department of Biomedical Sciences, University Center of Tonala, University of Guadalajara, Guadalajara 4542…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metabolic syndrome (MetS) is a group of physiological abnormalities characterized by obesity, insulin resistance (IR), and hypertriglyceridemia, which carry the risk of developing cardiovascular disease (CVD) and type 2 diabetes (T2D). Immune and metabolic alterations have been observed in MetS and are associated with autoimmune development. Systemic lupus erythematosus (SLE) is an autoimmune disease caused by a complex interaction of environmental, hormonal, and genetic factors and hyperactivation of immune cells. Patients with SLE have a high prevalence of MetS, in which elevated CVD is observed. Among the efforts of multidisciplinary healthcare teams to make an early diagnosis, a wide variety of factors have been considered and associated with the generation of biomarkers. This review aimed to elucidate some primary biomarkers and propose a set of assessments to improve the projection of the diagnosis and evolution of patients. These biomarkers include metabolic profiles, cytokines, cardiovascular tests, and microRNAs (miRs), which have been observed to be dysregulated in these patients and associated with outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Multidisciplinary Health Research Center, Department of Biomedical Sciences, University Center of Tonala, University of Guadalajara, Guadalajara 45425, Jalisco, Mexico.
- Department of Molecular Biology and Genomics, Institute of Rheumatology and Musculoskeletal System Research, University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico.
- Rheumatology Service, Internal Medicine Division, Civil Hospital of Guadalajara "Dr. Juan I. Menchaca", Guadalajara 44340, Jalisco, Mexico.
- Academic Group UDG-CA-703, "Immunology and Rheumatology", University Center of Health Sciences, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico.
ORCID-Profile: Fernanda Isadora Corona-Meraz, Mónica Vázquez-Del Mercado, Jesus-Aureliano Robles-De Anda, Alvaro-Jovanny Tovar-Cuevas, Milton-Omar Guzmán-Ornelas, Beatriz-Teresita Martín-Márquez
Zitieren
APA
Corona-Meraz, F. I., Vázquez-Del Mercado, M., Sandoval-García, F., Robles-De Anda, J. A., Tovar-Cuevas, A. J., Rosales-Gómez, R. C., Guzmán-Ornelas, M. O., González-Inostroz, D., Peña-Nava, M., & Martín-Márquez, B. T. (2024). Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome. Journal of Clinical Medicine, 13(7), 1988. https://doi.org/10.3390/jcm13071988
Vancouver
Corona-Meraz FI, Vázquez-Del Mercado M, Sandoval-García F, Robles-De Anda JA, Tovar-Cuevas AJ, Rosales-Gómez RC, et al. Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome. Journal of Clinical Medicine. 2024;13(7):1988. doi:10.3390/jcm13071988
BibTeX
@article{CoronaMeraz2024,
author = {Corona-Meraz, Fernanda Isadora and Vázquez-Del Mercado, Mónica and Sandoval-García, Flavio and Robles-De Anda, Jesus-Aureliano and Tovar-Cuevas, Alvaro-Jovanny and Rosales-Gómez, Roberto-Carlos and Guzmán-Ornelas, Milton-Omar and González-Inostroz, Daniel and Peña-Nava, Miguel and Martín-Márquez, Beatriz-Teresita},
title = {Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {7},
pages = {1988},
doi = {10.3390/jcm13071988}
}
EUVIMED